FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare
Syndicate content

Wyeth news from FierceVaccines

News

Whistleblowers allege problems with Wyeth's Prevnar

Two former Wyeth workers continue to cause controversy for Wyeth's blockbuster vaccine Prevnar. Wyeth disclosed recently that the workers' whistleblower suits accused the company of making false Read more...
Tags: vaccines   Wyeth   Prevnar   Anthony Sokol  

Press Releases

PRESS RELEASE: Raven biotechnologies and Wyeth Pharmaceuticals Extend Evaluation Period of Selected Raven Antibodies

Raven biotechnologies and Wyeth Pharmaceuticals Extend Evaluation Period of Selected Raven Antibodies SOUTH SAN FRANCISCO, Calif., Dec. 6 -- Raven biotechnologies, inc., a privately held company Read more...

PRESS RELEASE: Wyeth Consumer Healthcare Initiates Voluntary Recall and Replacement Program

Wyeth Consumer Healthcare Initiates Voluntary Recall and Replacement Program for Several Robitussin Products and Children's Dimetapp Cold & Chest Congestion -- Dosage Cup Being Replaced, No Read more...

PRESS RELEASE: Wyeth Jury Awards $99 Million Punitive Damages

Wyeth Jury Awards $99 Million Punitive Damages MADISON, N.J., Oct. 15 -- Wyeth confirmed today that it will appeal the verdict in the Scofield, Rowatt and Forrester v. Wyeth cases in the Second Read more...

PRESS RELEASE: Study Data Results Showed Desvenlafaxine Significantly Reduced Moderate to Severe Vasomotor Symptoms

Study Data Results Showed Desvenlafaxine Significantly Reduced Moderate to Severe Vasomotor Symptoms in Menopausal Women Versus Placebo COLLEGEVILLE, Pa., Oct. 15 -- Wyeth Pharmaceuticals, a Read more...

PRESS RELEASE: Wyeth Acquires Haptogen to Boost Biotechnology Drug Discovery

Wyeth Acquires Haptogen to Boost Biotechnology Drug Discovery COLLEGEVILLE, Pa., Oct. 5 -- Wyeth Pharmaceuticals, a division of Wyeth, announced today the signing of a definitive agreement under Read more...